Formations of, Acquisitions by, and Mergers of Bank Holding Companies, 76653-76654 [E8-29914]
Download as PDF
Federal Register / Vol. 73, No. 243 / Wednesday, December 17, 2008 / Notices
Connection also will carry the meeting
live via the Internet. To purchase these
services call (703) 993–3100 or go to
https://www.capitolconnection.gmu.edu.
Copies of materials adopted at this
meeting can be purchased from the
FCC’s duplicating contractor, Best Copy
and Printing, Inc. (202) 488–5300; Fax
(202) 488–5563; TTY (202) 488–5562.
These copies are available in paper
format and alternative media, including
large print/type; digital disk; and audio
and video tape. Best Copy and Printing,
Inc. may be reached by e-mail at
FCC@BCPIWEB.com.
Federal Communications Commission.
Marlene H. Dortch,
Secretary.
[FR Doc. E8–29910 Filed 12–12–08; 4:15 pm]
BILLING CODE 6712–01–P
FEDERAL COMMUNICATIONS
COMMISSION
Open Commission Meeting Scheduled
for Thursday, December 18, 2008,
Canceled
December 12, 2008.
The Federal Communications
Commission has canceled the Open
Meeting on the items listed below,
previously scheduled for Thursday,
December 18, 2008, at 445 12th Street,
SW., Washington, DC. The following
items will remain on circulation for the
Commissioners to vote:
Advanced Wireless Services (AWS)
• A Report and Order and Order on
Reconsideration addressing service
rules for fixed and mobile services,
including advanced wireless services
(AWS), in the 2155–2180 MHz band
(AWS–3).
• A Notice of Proposed Rulemaking
proposing a new digital television
translator service for analog loss areas.
pwalker on PROD1PC71 with NOTICES
• A Report and Order and Second
Report and Order and Order addressing
the a regulatory framework for the
coexistence of licensees in the Satellite
Digital Audio Radio Service (SDARS)
and the Wireless Communications
Service (WCS) in the 2305–2360 MHz
frequency band.
Wireless Radio Services (WRS)
Renewals
• A Notice of Proposed Rulemaking
and Order addressing Amendment of
Parts 1, 22, 24, 27, 74, 80, 90, 95, and
101 To Establish License Renewal and
Discontinuance of Operation Policies
and Procedures for Certain Wireless
Radio Services; Imposition of a Freeze
on the Filing of Competing Renewal
Applications for Certain Wireless Radio
Services and the Processing of AlreadyFiled Competing Renewal Applications.
Additional information concerning
this meeting may be obtained from
Audrey Spivack or David Fiske, Office
of Media Relations, (202) 418–0500;
TTY 1–888–835–5322.
Federal Communications Commission.
Marlene H. Dortch,
Secretary.
[FR Doc. E8–30100 Filed 12–15–08; 4:15 pm]
Notice of Agreement Filed
DTV Translators
DTV Consumer Education Notice of
Apparent Liability
• An omnibus NAL against various
companies for apparent violations of the
Commission’s DTV consumer education
requirements.
Jkt 217001
Regulatory Framework for SDARS and
WCS in the 2305–2360 MHz Band
FEDERAL MARITIME COMMISSION
• A Report and Order modifying the
program carriage rules and procedures
and a Further Notice of Proposed
Rulemaking seeking comment on the
practices of programmers and
broadcasters.
18:58 Dec 16, 2008
• A Second Report and Order
addressing the geographic area over
which wireless carriers must meet the
Enhanced 911 (E911) location accuracy
requirements.
BILLING CODE 6712–01–P
Program Carriage and Program Access
VerDate Aug<31>2005
E911 Location Accuracy
Requirements
The Commission hereby gives notice
of the filing of the following agreement
under the Shipping Act of 1984.
Interested parties may submit comments
on agreements to the Secretary, Federal
Maritime Commission, Washington, DC
20573, within ten days of the date this
notice appears in the Federal Register.
Copies of agreements are available
through the Commission’s Web site
(https://www.fmc.gov) or contacting the
Office of Agreements at (202) 523–5793
or tradeanalysis@fmc.gov.
Agreement No.: 012059.
Title: CSAV/NYK Venezuela Space
Charter Agreement.
Parties: Compania Sud Americana De
Vapores S.A. and Nippon Yusen Kaisha.
Filing Party: Michael B. Holt, Vice
President and General Counsel; NYK
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
76653
Line; 300 Lighting Way, 5th Floor;
Secaucus, NJ 07094.
Synopsis: The agreement authorizes
CSAV to charter space to NYK in the
trade from Newark, NJ, Baltimore, MD,
and Miami, FL, to ports in Venezuela.
By Order of the Federal Maritime
Commission.
Dated: December 12, 2008.
Tanga S. Fitzgibbon,
Alternate Federal Register Liaison Officer.
[FR Doc. E8–29945 Filed 12–16–08; 8:45 am]
BILLING CODE 6730–01–P
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR Part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications also will be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Additional information on all bank
holding companies may be obtained
from the National Information Center
website at www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than January 12,
2009.
A. Federal Reserve Bank of New
York (Anne MacEwen, Bank
Applications Officer) 33 Liberty Street,
New York, New York 10045-0001:
1. Morgan Stanley, New York, New
York; to acquire additional common
E:\FR\FM\17DEN1.SGM
17DEN1
76654
Federal Register / Vol. 73, No. 243 / Wednesday, December 17, 2008 / Notices
shares up to 9.9 percent of the voting
shares of Chinatrust Financial Holding
Company, Ltd., Taipei, Taiwan, and
thereby acquire Chinatrust Bank
(U.S.A.), Torrance, California.
Board of Governors of the Federal Reserve
System, December 12, 2008.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E8–29913 Filed 12–16–08; 8:45 am]
Board of Governors of the Federal Reserve
System, December 12, 2008.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E8–29914 Filed 12–16–08; 8:45 am]
BILLING CODE 6210–01–S
BILLING CODE 6210–01–S
Food and Drug Administration
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Docket No. FDA–2008–N–0439]
FEDERAL RESERVE SYSTEM
pwalker on PROD1PC71 with NOTICES
Notice of Proposals to Engage in
Permissible Nonbanking Activities or
to Acquire Companies that are
Engaged in Permissible Nonbanking
Activities
The companies listed in this notice
have given notice under section 4 of the
Bank Holding Company Act (12 U.S.C.
1843) (BHC Act) and Regulation Y (12
CFR Part 225) to engage de novo, or to
acquire or control voting securities or
assets of a company, including the
companies listed below, that engages
either directly or through a subsidiary or
other company, in a nonbanking activity
that is listed in § 225.28 of Regulation Y
(12 CFR 225.28) or that the Board has
determined by Order to be closely
related to banking and permissible for
bank holding companies. Unless
otherwise noted, these activities will be
conducted throughout the United States.
Each notice is available for inspection
at the Federal Reserve Bank indicated.
The notice also will be available for
inspection at the offices of the Board of
Governors. Interested persons may
express their views in writing on the
question whether the proposal complies
with the standards of section 4 of the
BHC Act. Additional information on all
bank holding companies may be
obtained from the National Information
Center website at www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding the applications must be
received at the Reserve Bank indicated
or the offices of the Board of Governors
not later than January 12, 2008.
A. Federal Reserve Bank of
Richmond (A. Linwood Gill, III, Vice
President) 701 East Byrd Street,
Richmond, Virginia 23261-4528:
1. Capital One Financial Corporation,
McLean, Virginia; to acquire Chevy
Chase Bank, Federal Savings Bank,
McLean, Virginia, and thereby engage in
operation a savings and loan association
pursuant to section 225.28(b)(4)(ii) of
Regulation Y.
VerDate Aug<31>2005
18:58 Dec 16, 2008
Jkt 217001
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Blood
Establishment Registration and
Product Listing, Form FDA 2830
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by January 16,
2009.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–6974, or e-mailed to
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0052. Also
include the FDA docket number found
in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT:
Jonna Capezzuto, Office of Information
Management (HFA–710), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301–796–3794.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
Blood Establishment Registration and
Product Listing, Form FDA 2830—
(OMB Control Number 0910–0052)—
Extension
Under section 510 of the Federal
Food, Drug, and Cosmetic Act (21 U.S.C.
360), any person owning or operating an
establishment that manufactures,
prepares, propagates, compounds, or
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
processes a drug or device must register
with the Secretary of Health and Human
Services, on or before December 31 of
each year, his or her name, place of
business, and all such establishments,
and must submit, among other
information, a listing of all drug or
device products manufactured,
prepared, propagated, compounded, or
processed by him or her for commercial
distribution. In part 607 (21 CFR part
607), FDA has issued regulations
implementing these requirements for
manufacturers of human blood and
blood products.
Section 607.20(a), in brief, requires
owners or operators of certain
establishments that engage in the
manufacture of blood products to
register and to submit a list of every
blood product in commercial
distribution. Section 607.21, in brief,
requires the owners or operators of
establishments entering into the
manufacturing of blood products to
register within 5 days after beginning
such operation and to submit a list of
every blood product in commercial
distribution at the time. If the owner or
operator of the establishment has not
previously entered into such operation
for which a license is required,
registration must follow within 5 days
after the submission of a biologics
license application. In addition,
establishments are required to register
annually between November 15 and
December 31 and update their blood
product listing every June and
December of each year. Section 607.22
requires the use of Form FDA 2830,
Blood Establishment Registration and
Product Listing, for initial registration,
for annual registration, and for blood
product listing. Section 607.25 indicates
the information required for
establishment registration and blood
product listing. Section 607.26, in brief,
requires certain changes to be submitted
on FDA Form 2830 as amendments to
the establishment registration within 5
days of such changes. Section 607.30(a),
in brief, indicates the information
required for owners or operators of
establishments to update their blood
product listing information every June
and December, or at the discretion of the
registrant at the time the change occurs.
Section 607.31 requires that additional
blood product listing information be
provided upon FDA request. Section
607.40, in brief, requires certain foreign
blood product establishments to register
and submit the blood product listing
information, and to provide the name
and address of the establishment and
the name of the individual responsible
for submitting blood product listing
E:\FR\FM\17DEN1.SGM
17DEN1
Agencies
[Federal Register Volume 73, Number 243 (Wednesday, December 17, 2008)]
[Notices]
[Pages 76653-76654]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-29914]
=======================================================================
-----------------------------------------------------------------------
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and Mergers of Bank Holding
Companies
The companies listed in this notice have applied to the Board for
approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C.
1841 et seq.) (BHC Act), Regulation Y (12 CFR Part 225), and all other
applicable statutes and regulations to become a bank holding company
and/or to acquire the assets or the ownership of, control of, or the
power to vote shares of a bank or bank holding company and all of the
banks and nonbanking companies owned by the bank holding company,
including the companies listed below.
The applications listed below, as well as other related filings
required by the Board, are available for immediate inspection at the
Federal Reserve Bank indicated. The applications also will be available
for inspection at the offices of the Board of Governors. Interested
persons may express their views in writing on the standards enumerated
in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the
acquisition of a nonbanking company, the review also includes whether
the acquisition of the nonbanking company complies with the standards
in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted,
nonbanking activities will be conducted throughout the United States.
Additional information on all bank holding companies may be obtained
from the National Information Center website at www.ffiec.gov/nic/.
Unless otherwise noted, comments regarding each of these
applications must be received at the Reserve Bank indicated or the
offices of the Board of Governors not later than January 12, 2009.
A. Federal Reserve Bank of New York (Anne MacEwen, Bank
Applications Officer) 33 Liberty Street, New York, New York 10045-0001:
1. Morgan Stanley, New York, New York; to acquire additional common
[[Page 76654]]
shares up to 9.9 percent of the voting shares of Chinatrust Financial
Holding Company, Ltd., Taipei, Taiwan, and thereby acquire Chinatrust
Bank (U.S.A.), Torrance, California.
Board of Governors of the Federal Reserve System, December 12,
2008.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E8-29914 Filed 12-16-08; 8:45 am]
BILLING CODE 6210-01-S